Cite

HARVARD Citation

    Beuselinck, B. et al. (n.d.). Prognostic impact of baseline serum C‐reactive protein in patients with metastatic renal cell carcinoma (RCC) treated with sunitinib. BJU international. pp. 81-89. [Online]. 
  
Back to record